<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39616027</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-8989</ISSN><JournalIssue CitedMedium="Internet"><Volume>164</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>11</Day></PubDate></JournalIssue><Title>Medicina clinica</Title><ISOAbbreviation>Med Clin (Barc)</ISOAbbreviation></Journal><ArticleTitle>Use of intravenous calcium in emergencies to treat patients with hyperkalemia and digoxin poisoning and its impact on short-term outcome.</ArticleTitle><Pagination><StartPage>334</StartPage><EndPage>340</EndPage><MedlinePgn>334-340</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.medcli.2024.10.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0025-7753(24)00666-3</ELocationID><Abstract><AbstractText Label="OBJETIVES" NlmCategory="OBJECTIVE">Patients with digitalis intoxication (DI) and hyperkalaemia are frequently encountered in the emergency department (ED). This alteration may require intravenous (iv) calcium, but its administration has been considered to increase cardiotoxicity and mortality in patients with DI. We studied the effect of iv calcium on mortality and 30-day readmission in patients with hyperkalaemia and DI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective, multicentre, retrospective cohort study including all patients with DI and hyperkalaemia from 2004 to 2023 seen in 6 hospital emergency departments. Two cohorts were created according to iv calcium administration, and demographic, clinical, electrocardiographic and outcome variables (mortality, readmission and combined event at 30 days) were collected.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">117 patients with ID and hyperkalaemia were collected and 29% were administered iv calcium. Seventy-eight point 6percent were women, with a median age of 82.8 years. Cardiological symptoms were present in 57.3%, 47% digestive and 37.6% neurological. Cardiac arrhythmia was present in 86.3%, the most frequent type being slow supraventricular arrhythmia in 76.1%. The presence of cardiological symptoms (76.5% vs. 49.4, P=.007), arrhythmias (97.1% vs. 81.9%, P=.037), and higher levels of creatinine (70.6% vs. 42.2%, P=.005) and serum potassium (94.1% vs. 31.3%, P&lt;.001) was more frequent in the group receiving iv calcium. An association was found between the administration of iv calcium An association was found between calcium administration and the combined event at 30 days (ORa 3.11, 95% CI:1.02-9.53), but this increase was at the expense of more readmissions (ORa 3.58, 95% CI, 1.04-12,33), with no relationship found with mortality at 30 days (ORa 0,75, 95% CI: 0.18-3.09).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Calcium administration in hyperkalaemia and ID is not associated with short-term mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Llorens</LastName><ForeName>Pere</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Corta Estancia y Hospitalizaci&#xf3;n a Domicilio, Hospital General Dr. Balmis, Instituto de Investigaci&#xf3;n Sanitaria y Biom&#xe9;dica de Alicante (ISABIAL), Universidad Miguel Hern&#xe1;ndez de Elche, Alicante, Espa&#xf1;a. Electronic address: llorens_ped@gva.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mataix</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Corta Estancia y Hospitalizaci&#xf3;n a Domicilio, Hospital General Dr. Balmis, Instituto de Investigaci&#xf3;n Sanitaria y Biom&#xe9;dica de Alicante (ISABIAL), Universidad Miguel Hern&#xe1;ndez de Elche, Alicante, Espa&#xf1;a; Servicio de Medicina Intensiva, Hospital General Dr. Balmis, Alicante, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez Tejera</LastName><ForeName>Matilde</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital General Universitario de Elche, Universidad Miguel Hern&#xe1;ndez de Elche, Alicante, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serrano</LastName><ForeName>Leticia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Polit&#xe9;cnico La Fe, Valencia, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrero-Puente</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario Central de Asturias, Instituto de Investigaci&#xf3;n Biosanitaria del Principado de Asturias (ISPA), Oviedo, Asturias, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Grima</LastName><ForeName>Mar&#xed;a Luisa</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Dr. Peset, Valencia, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espinosa</LastName><ForeName>Bego&#xf1;a</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Corta Estancia y Hospitalizaci&#xf3;n a Domicilio, Hospital General Dr. Balmis, Instituto de Investigaci&#xf3;n Sanitaria y Biom&#xe9;dica de Alicante (ISABIAL), Universidad Miguel Hern&#xe1;ndez de Elche, Alicante, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucas-Imbern&#xf3;n</LastName><ForeName>Francisco Javier</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital General Universitario de Albacete, Albacete, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-D&#xed;ez</LastName><ForeName>Mar&#xed;a Pilar</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario de Burgos, Burgos, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mill&#xe1;n</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Polit&#xe9;cnico La Fe, Valencia, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallardo Rodr&#xed;guez</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Medina Preventiva, Hospital General Dr. Balmis, Alicante, Instituto de Investigaci&#xf3;n Sanitaria y Biom&#xe9;dica de Alicante (ISABIAL), Departamento de Enfermer&#xed;a Comunitaria, Medicina Preventiva y Salud P&#xfa;blica e Historia de la Ciencia de la Salud. Universidad de Alicante, Alicante, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chico-S&#xe1;nchez</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Medina Preventiva, Hospital General Dr. Balmis, Alicante, Instituto de Investigaci&#xf3;n Sanitaria y Biom&#xe9;dica de Alicante (ISABIAL), Departamento de Enfermer&#xed;a Comunitaria, Medicina Preventiva y Salud P&#xfa;blica e Historia de la Ciencia de la Salud. Universidad de Alicante, Alicante, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mas</LastName><ForeName>Patricio</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Farmacia Hospitalaria, Hospital General Dr. Balmis, Alicante, Instituto de Investigaci&#xf3;n Sanitaria y Biom&#xe9;dica de Alicante (ISABIAL), Alicante, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lafuente</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>&#xc1;rea de gesti&#xf3;n cl&#xed;nica del Laboratorio de Medicina, Hospital Universitario Central de Asturias, Instituto de Investigaci&#xf3;n Biosanitaria del Principado de Asturias (ISPA), Oviedo, Asturias, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calz&#xf3;n Blanco</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>&#xc1;rea de gesti&#xf3;n cl&#xed;nica del Laboratorio de Medicina, Hospital Universitario Central de Asturias, Instituto de Investigaci&#xf3;n Biosanitaria del Principado de Asturias (ISPA), Oviedo, Asturias, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mir&#xf3;</LastName><ForeName>&#xd2;scar</ForeName><Initials>&#xd2;</Initials><AffiliationInfo><Affiliation>&#xc1;rea de Urgencias, Hospital Cl&#xed;nic Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><VernacularTitle>Uso de calcio por v&#xed;a intravenosa en urgencias para tratar pacientes con hiperpotasemia e intoxicaci&#xf3;n por digoxina y su impacto en la evoluci&#xf3;n a corto plazo.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Med Clin (Barc)</MedlineTA><NlmUniqueID>0376377</NlmUniqueID><ISSNLinking>0025-7753</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical><Chemical><RegistryNumber>73K4184T59</RegistryNumber><NameOfSubstance UI="D004077">Digoxin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006947" MajorTopicYN="Y">Hyperkalemia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="Y">Calcium</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004077" MajorTopicYN="Y">Digoxin</DescriptorName><QualifierName UI="Q000506" MajorTopicYN="N">poisoning</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010359" MajorTopicYN="N">Patient Readmission</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061605" MajorTopicYN="N">Administration, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004630" MajorTopicYN="N">Emergencies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Calcium</Keyword><Keyword MajorTopicYN="N">Digoxin</Keyword><Keyword MajorTopicYN="N">Digoxina</Keyword><Keyword MajorTopicYN="N">Emergency department</Keyword><Keyword MajorTopicYN="N">Hiperpotasemia</Keyword><Keyword MajorTopicYN="N">Hyperkalaemia</Keyword><Keyword MajorTopicYN="N">Intoxicaci&#xf3;n</Keyword><Keyword MajorTopicYN="N">Intoxication</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Pron&#xf3;stico</Keyword><Keyword MajorTopicYN="N">Urgencias</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>5</Day><Hour>15</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>1</Day><Hour>15</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>30</Day><Hour>21</Hour><Minute>57</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39616027</ArticleId><ArticleId IdType="doi">10.1016/j.medcli.2024.10.007</ArticleId><ArticleId IdType="pii">S0025-7753(24)00666-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38607301</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2386-5857</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title><ISOAbbreviation>Emergencias</ISOAbbreviation></Journal><ArticleTitle>Long-term risk of death in patients with infection attended by prehospital emergency services.</ArticleTitle><Pagination><StartPage>88</StartPage><EndPage>96</EndPage><MedlinePgn>88-96</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.55633/s3me/023.2023</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To develop and validate a risk model for 1-year mortality based on variables available from early prehospital emergency attendance of patients with infection.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Prospective, observational, noninterventional multicenter study in adults with suspected infection transferred to 4 Spanish hospitals by advanced life-support ambulances from June 1, 2020, through June 30, 2022. We collected demographic, physiological, clinical, and analytical data. Cox regression analysis was used to develop and validate a risk model for 1-year mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Four hundred ten patients were enrolled (development cohort, 287; validation cohort, 123). Cumulative mortality was 49% overall. Sepsis (infection plus a Sepsis-related Organ Failure Assessment score of 2 or higher) was diagnosed in 29.2% of survivors vs 56.7% of nonsurvivors. The risk model achieved an area under the receiver operating characteristic curve of 0.89 for 1-year mortality. The following predictors were included in the model: age; institutionalization; age-adjusted Charlson comorbidity index; PaCO2; potassium, lactate, urea nitrogen, and creatinine levels; fraction of inspired oxygen; and diagnosed sepsis.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The model showed excellent ability to predict 1-year mortality based on epidemiological, analytical, and clinical variables, identifying patients at high risk of death soon after their first contact with the health care system.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Melero Guijarro</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario Rio Hortega de Valladolid, Gerencia Regional de Salud de Castilla y Le&#xf3;n (SACYL), Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;n-Rodr&#xed;guez</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad de Valladolid, Espa&#xf1;a. Gerencia de Emergencias Sanitarias, Gerencia Regional de Salud de Castilla y Le&#xf3;n (SACYL), Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1;lvarez Manzanares</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario Rio Hortega de Valladolid, Gerencia Regional de Salud de Castilla y Le&#xf3;n (SACYL), Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Pozo Vegas</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Cl&#xed;nico Universitario de Valladolid, Gerencia Regional de Salud de Castilla y Le&#xf3;n (SACYL), Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanz Garc&#xed;a</LastName><ForeName>Ancor</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Facultad de Ciencias de la Salud, Universidad de Castilla la Mancha, Talavera de la Reina, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro Villamor</LastName><ForeName>Miguel &#xc1;ngel</ForeName><Initials>M&#xc1;</Initials><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad de Valladolid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Izquierdo</LastName><ForeName>Ra&#xfa;l</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario Rio Hortega de Valladolid, Gerencia Regional de Salud de Castilla y Le&#xf3;n (SACYL), Espa&#xf1;a. Facultad de Medicina, Universidad de Valladolid, Espa&#xf1;a. CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><VernacularTitle>Modelo de riesgo de mortalidad a largo plazo en pacientes con infecci&#xf3;n atendidos por servicios de emergencias prehospitalarios.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Emergencias</MedlineTA><NlmUniqueID>9805751</NlmUniqueID><ISSNLinking>1137-6821</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>33X04XA5AT</RegistryNumber><NameOfSubstance UI="D019344">Lactic Acid</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Population" UI="C000724586">Spaniard people</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000552" MajorTopicYN="N">Ambulances</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004632" MajorTopicYN="Y">Emergency Medical Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019344" MajorTopicYN="N">Lactic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094854" MajorTopicYN="N" AutoHM="Y">European People</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">Dise&#xf1;ar y validar un modelo de riesgo con variables determinadas a nivel prehospitalario para predecir el riesgo de mortalidad a largo plazo (1 a&#xf1;o) en pacientes con infecci&#xf3;n.</AbstractText><AbstractText Label="METODO" NlmCategory="METHODS">Estudio multic&#xe9;ntrico, observacional prospectivo, sin intervenci&#xf3;n, en pacientes adultos con sospecha infecci&#xf3;n atendidos por unidades de soporte vital avanzado y trasladados a 4 hospitales espa&#xf1;oles entre el 1 de junio de 2020 y el 30 de junio de 2022. Se recogieron variables demogr&#xe1;ficas, fisiol&#xf3;gicas, cl&#xed;nicas y anal&#xed;ticas. Se construy&#xf3; y valid&#xf3; un modelo de riesgo para la mortalidad a un a&#xf1;o usando una regresi&#xf3;n de Cox.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">Se incluyeron 410 pacientes, con una tasa de mortalidad acumulada al a&#xf1;o del 49%. La tasa de diagn&#xf3;stico de sepsis (infecci&#xf3;n e incremento sobre el SOFA basal $ 2 puntos) fue del 29,2% en supervivientes frente a un 56,7% en no supervivientes. El modelo predictivo obtuvo un &#xe1;rea bajo la curva de la caracter&#xed;stica operativa del receptor para la mortalidad a un a&#xf1;o fue de 0,89, e incluy&#xf3;: edad, institucionalizaci&#xf3;n, &#xed;ndice de comorbilidad de Charlson ajustado por edad, presi&#xf3;n parcial de di&#xf3;xido de carbono, potasio, lactato, nitr&#xf3;geno ureico en sangre, creatinina, saturaci&#xf3;n en relaci&#xf3;n con fracci&#xf3;n inspirada de ox&#xed;geno y diagn&#xf3;stico de sepsis.</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="CONCLUSIONS">El modelo desarrollado con variables epidemiol&#xf3;gicas, anal&#xed;ticas y cl&#xed;nicas mostr&#xf3; una excelente capacidad predictiva, y permiti&#xf3; identificar desde el primer contacto del paciente con el sistema sanitario, a modo de evento centinela, casos de alto riesgo.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Decision making</Keyword><Keyword MajorTopicYN="N">Emergency health services</Keyword><Keyword MajorTopicYN="N">Infecci&#xf3;n</Keyword><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Pron&#xf3;stico</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Servicios de emergencias m&#xe9;dicos</Keyword><Keyword MajorTopicYN="N">Toma de decisiones cl&#xed;nicas</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>12</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>12</Day><Hour>10</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38607301</ArticleId><ArticleId IdType="doi">10.55633/s3me/023.2023</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32993921</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2173-5786</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Actas urologicas espanolas</Title><ISOAbbreviation>Actas Urol Esp (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Assessment of trends and clinical presentation in the emergency department of patients with renal colic during the COVID-19 pandemic era.</ArticleTitle><Pagination><StartPage>653</StartPage><EndPage>658</EndPage><MedlinePgn>653-658</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.acuro.2020.08.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0210-4806(20)30190-X</ELocationID><Abstract><AbstractText Label="INTRODUCTION">We hypothesized that the recent COVID-19 pandemic may lead to a delay in renal colic patients presenting to the Emergency Department due to the fear of getting infected. This delay may lead to a more severe clinical condition at presentation with possible complications for the patients.</AbstractText><AbstractText Label="MATERIAL AND METHODS">Retrospective review of data collected from three institutions from Spain and Italy. Patients who presented to Emergency Department with unilateral or bilateral renal colic caused by imaging confirmed urolithiasis during the 45 days before and after each national lockdown were included. Data collected included patients' demographics, biochemical urine and blood tests, radiological tests, signs, symptoms and the therapeutic management. Analysis was performed between two groups, Group A: patients presenting prior to the national lockdown date; and Group B: patients presenting after the national lockdown date.</AbstractText><AbstractText Label="RESULTS">A total of 397 patients presented to Emergency Department with radiology confirmed urolithiasis and were included in the study. The number of patients presenting to Emergency Department with renal/ureteric colic was 285 (71.8%) patients in Group A and 112 (28.2%) patients in Group B (p&lt;0.001). The number of patients reporting a delay in presentation was 135 (47.4%) in Group A and 63 (56.3%) in Group B (p=0.11). At presentation, there were no statistical differences between Group A and Group B regarding the serum creatinine level, C reactive protein, white blood cell count, fever, oliguria, flank pain and hydronephrosis. In addition, no significant differences were observed with the length of stay, Urology department admission requirement and type of therapy.</AbstractText><AbstractText Label="CONCLUSION">Data from our study showed a significant reduction in presentations to Emergency Department for renal colic after the lockdown in Spain and Italy. However, we did not find any significant difference with the length of stay, Urology department admission requirement and type of therapy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 AEU. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carrion</LastName><ForeName>D M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Urology Department, La Paz University Hospital, Autonomous University of Madrid, Madrid, Espa&#xf1;a; European Society of Residents in Urology (ESRU).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantica</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>European Society of Residents in Urology (ESRU); Department of Urology, Policlinico San Martino Hospital, University of Genova, G&#xe9;nova, Italia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ant&#xf3;n-Juanilla M</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Urology, Cruces University Hospital, Barakaldo, Vizcaya, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>K H</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>European Society of Residents in Urology (ESRU); Department of Oncology and Metabolism, Academic Urology Unit, University of Sheffield, Sheffield, Reino Unido.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tappero</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Urology, Policlinico San Martino Hospital, University of Genova, G&#xe9;nova, Italia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Serrano</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Urology Department, La Paz University Hospital, Autonomous University of Madrid, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parodi</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Urology, Policlinico San Martino Hospital, University of Genova, G&#xe9;nova, Italia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crespo-At&#xed;n</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Urology, Cruces University Hospital, Barakaldo, Vizcaya, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cansino</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Urology Department, La Paz University Hospital, Autonomous University of Madrid, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terrone</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Urology, Policlinico San Martino Hospital, University of Genova, G&#xe9;nova, Italia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nikles</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>European Society of Residents in Urology (ESRU); Department of Urology, Sestre Milosrdnice University Hospital Centre, Zagreb, Croacia. Electronic address: sven.nikles@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomez Rivas</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Urology Department, La Paz University Hospital, Autonomous University of Madrid, Madrid, Espa&#xf1;a; European Society of Residents in Urology (ESRU).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esperto</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>European Society of Residents in Urology (ESRU); Department of Urology, Campus Biomedico, University of Rome, Roma, Italia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><VernacularTitle>Evaluaci&#xf3;n de las tendencias y presentaci&#xf3;n cl&#xed;nica de pacientes con c&#xf3;lico nefr&#xed;tico que acuden al servicio de urgencias durante la era pand&#xe9;mica del COVID-19.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Actas Urol Esp (Engl Ed)</MedlineTA><NlmUniqueID>101771154</NlmUniqueID><ISSNLinking>2173-5786</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056844" MajorTopicYN="N">Renal Colic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014514" MajorTopicYN="N">Ureteral Calculi</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="INTRODUCCI&#xd3;N">Nuestra hip&#xf3;tesis es que la pandemia por COVID-19, y el estado de alarma impuesto por los gobiernos, pueden haber retrasado las visitas a urgencias por c&#xf3;licos nefr&#xed;ticos, debido al miedo a contagiarse en los centros sanitarios. Este atraso en acudir a los servicios de urgencias puede llevar a un empeoramiento cl&#xed;nico y aumentar las complicaciones relacionadas con la enfermedad o el tratamiento recibido.</AbstractText><AbstractText Label="MATERIAL Y M&#xc9;TODOS">Realizamos una revisi&#xf3;n retrospectiva de 3 centros hospitalarios en Espa&#xf1;a e Italia. Fueron incluidos pacientes atendidos en el servicio de urgencias por c&#xf3;lico renal (unilateral o bilateral) secundario a litiasis confirmadas en pruebas de imagen durante los 45 d&#xed;as previos y posteriores a la declaraci&#xf3;n del estado de alarma de cada pa&#xed;s. Se recolectaron datos demogr&#xe1;ficos, s&#xed;ntomas y signos de presentaci&#xf3;n, an&#xe1;lisis de sangre y orina, pruebas de imagen, y manejo terap&#xe9;utico. El an&#xe1;lisis estad&#xed;stico se realiz&#xf3; entre dos grupos, Grupo A: pacientes que acudieron antes de la declaraci&#xf3;n del estado de alarma y Grupo B: pacientes que acudieron tras la declaraci&#xf3;n del estado de alarma.</AbstractText><AbstractText Label="RESULTADOS">Un total de 397 pacientes que acudieron a urgencias por c&#xf3;licos nefr&#xed;ticos secundarios a litiasis fueron incluidos en el estudio, 285 (71,8%) en el Grupo A y 112 (28,2%) en el Grupo B (<i>p</i>&#xa0;&lt;&#xa0;0,001). Un total de 135 (47,4%) en el Grupo A y 63 (56,3%) en el Grupo B (<i>p</i>&#xa0;=&#xa0;0,11) admitieron haber pospuesto su b&#xfa;squeda de atenci&#xf3;n m&#xe9;dica urgente. En el momento de la valoraci&#xf3;n inicial, no se encontraron diferencias entre ambos grupos en los niveles de creatinina s&#xe9;rica, leucocitosis, fiebre, oliguria, dolor, o hidronefrosis. Adem&#xe1;s, no se observaron diferencias en relaci&#xf3;n con la estancia media, ingreso en el servicio de urolog&#xed;a, o necesidad de tratamientos invasivos.</AbstractText><AbstractText Label="CONCLUSI&#xd3;N">Nuestros resultados muestran una disminuci&#xf3;n significativa de atenciones en urgencias por c&#xf3;licos nefr&#xed;ticos tras la declaraci&#xf3;n del estado de alarma en Espa&#xf1;a e Italia. A diferencia de otros estudios publicados recientemente, no encontramos diferencias en la estancia media, ingreso al servicio de urolog&#xed;a, o necesidad de tratamientos invasivos en pacientes que se presentaron antes y despu&#xe9;s del estado de alarma.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 AEU. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">C&#xf3;licos nefr&#xed;ticos</Keyword><Keyword MajorTopicYN="N">C&#xf3;licos renales</Keyword><Keyword MajorTopicYN="N">Emergency department</Keyword><Keyword MajorTopicYN="N">Lithiasis</Keyword><Keyword MajorTopicYN="N">Litiasis</Keyword><Keyword MajorTopicYN="N">Renal coli</Keyword><Keyword MajorTopicYN="N">Servicio de urgencias</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>30</Day><Hour>5</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>11</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32993921</ArticleId><ArticleId IdType="pmc">PMC7676381</ArticleId><ArticleId IdType="doi">10.1016/j.acuro.2020.08.006</ArticleId><ArticleId IdType="pii">S0210-4806(20)30190-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization; 2020. WHO statement regarding cluster of pneumonia cases in Wuhan, China [Internet] Available from:  https://www.who.int/china/news/detail/09-01-2020-who-statement-regarding-cluster-of-pneumonia-cases-in-wuhan-china [accessed 29.03.20]</Citation></Reference><Reference><Citation>Wilder-Smith A., Freedman D. Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. J Travel Med. 2020;27 doi: 10.1093/jtm/taaa020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taaa020</ArticleId><ArticleId IdType="pmc">PMC7107565</ArticleId><ArticleId IdType="pubmed">32052841</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam C.F., Cheung K.S., Lam S., Wong A., Yung A., Sze M., et al. Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes. 2020;13:e006631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7147280</ArticleId><ArticleId IdType="pubmed">32182131</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini M., Barbi E., Apicella A., Marchetti F., Cardinale F., Trobia G. Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health. 2020;4:e10&#x2013;e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146704</ArticleId><ArticleId IdType="pubmed">32278365</ArticleId></ArticleIdList></Reference><Reference><Citation>De Filippo O., D&#x2019;Ascenzo F., Angelini F., Bocchino P.P., Conrotto F., Saglieto A., et al. Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy. N Engl J Med. 2020;383:88&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7224608</ArticleId><ArticleId IdType="pubmed">32343497</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantica G., Riccardi N., Terrone C., Gratarola A. Non-COVID-19 visits to emergency departments during the pandemic: the impact of fear. Public Health. 2020;183:40&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7203034</ArticleId><ArticleId IdType="pubmed">32417567</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantica G., Suardi N., Terrone C. Re: Ming-Chun Chan, Sharon E.K. Yeo, Yew-Lam Chong, Yee-Mun Lee. Stepping Forward: Urologists&#x2019; efforts during the COVID-19 Outbreak in Singapore. Eur Urol. 2020;78:e42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269695</ArticleId><ArticleId IdType="pubmed">32192816</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonucci M., Recupero S.M., Marzio V., De Dominicis M., Pinto F., Foschi N., et al. El impacto de la COVID-19 en las admisiones al servicio de urgencias, hospitalizaciones y manejo cl&#xed;nico de la urolitiasis en el centro de Italia: an&#xe1;lisis multic&#xe9;ntrico. Actas Urol Esp. 2020 doi: 10.1016/j.acuro.2020.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acuro.2020.06.005</ArticleId><ArticleId IdType="pmc">PMC7332912</ArticleId><ArticleId IdType="pubmed">32713658</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;3(Suppl.):1&#x2013;150.</Citation></Reference><Reference><Citation>Matthewson J., Tiplady A., Gerakios F., Foley A., Murphy E. Implementation and analysis of a telephone support service during COVID-19. Occup Med (Lond) 2020;70:375&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7313817</ArticleId><ArticleId IdType="pubmed">32449754</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervino G., Oteri G. COVID-19 pandemic and telephone triage before attending Medical Office: problem or opportunity? Medicina (Kaunas) 2020;56:250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7279364</ArticleId><ArticleId IdType="pubmed">32443828</ArticleId></ArticleIdList></Reference><Reference><Citation>Judson T.J., Odisho A.Y., Neinstein A.B., Chao J., Williams A., Miller C., et al. Rapid design and implementation of an integrated patient self-triage and self-scheduling tool for COVID-19. J Am Med Inform Assoc. 2020;27:860&#x2013;866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184478</ArticleId><ArticleId IdType="pubmed">32267928</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas R.S., Cooper J.L., Hempel E.V. COVID-19 risk triage: engaging residents in telephonic screening. Med Educ. 2020;54:670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267521</ArticleId><ArticleId IdType="pubmed">32363615</ArticleId></ArticleIdList></Reference><Reference><Citation>Miah S., Gunner C., Clayton L., Venugopal S., Boucher N.R., Parys B. Renal colic and childbirth pain: female experience versus male perception. J Pain Res. 2017;10:1553&#x2013;1554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5505545</ArticleId><ArticleId IdType="pubmed">28740421</ArticleId></ArticleIdList></Reference><Reference><Citation>Flammia S., Salciccia S., Tufano A., Busetto G.M., Ricciuti G.P., Sciarra A. How urinary stone emergencies changed in the time of COVID-19? [published online ahead of print, 2020 May 28] Urolithiasis. 2020:1&#x2013;3. doi: 10.1007/s00240-020-01198-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00240-020-01198-3</ArticleId><ArticleId IdType="pmc">PMC7255446</ArticleId><ArticleId IdType="pubmed">32468127</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribal M.J., Cornford P., Briganti A., Knoll T., Gravas S., Babjuk M., et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol. 2020;78:21&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7183974</ArticleId><ArticleId IdType="pubmed">32376137</ArticleId></ArticleIdList></Reference><Reference><Citation>Proietti S., Gaboardi F., Giusti G. Endourological stone management in the Era of the COVID-19. Eur Urol. 2020;78:131&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195508</ArticleId><ArticleId IdType="pubmed">32303384</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32657550</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1988-9518</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia</Title><ISOAbbreviation>Rev Esp Quimioter</ISOAbbreviation></Journal><ArticleTitle>[Potential biomarkers predictors of mortality in COVID-19 patients in the Emergency Department].</ArticleTitle><Pagination><StartPage>267</StartPage><EndPage>273</EndPage><MedlinePgn>267-273</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.37201/req/060.2020</ELocationID><ELocationID EIdType="pii" ValidYN="Y">pascual13jul2020</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Identify which biomarkers performed in the first emergency analysis help to stratify COVID-19 patients according to mortality risk.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Observational, descriptive and cross-sectional study performed with data collected from patients with suspected COVID-19 in the Emergency Department from February 24 to March 16, 2020. The univariate and multivariate study was performed to find independent mortality markers and calculate risk by building a severity score.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 163 patients were included, of whom 33 died and 29 of them were positive for the COVID-19 PCR test. We obtained as possible factors to conform the Mortality Risk Score age&gt; 75 years ((adjusted OR = 12,347, 95% CI: 4,138-36,845 p = 0.001), total leukocytes&gt; 11,000 cells / mm3 (adjusted OR = 2,649, 95% CI: 0.879-7.981 p = 0.083), glucose&gt; 126 mg / dL (adjusted OR = 3.716, 95% CI: 1.247-11.074 p = 0.018) and creatinine&gt; 1.1 mg / dL (adjusted OR = 2.566, 95% CI: 0.889- 7.403, p = 0.081) This score was called COVEB (COVID, Age, Basic analytical profile) with an AUC 0.874 (95% CI: 0.816-0.933, p &lt;0.001; Cut-off point = 1 (sensitivity = 89.66 % (95% CI: 72.6% -97.8%), specificity = 75.59% (95% CI: 67.2% -82.8%). A score &lt;1 has a negative predictive value = 100% (95% CI: 93.51% -100%) and a positive predictive value = 18.59% (95% CI: 12.82% -25.59%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Clinical severity scales, kidney function biomarkers, white blood cell count parameters, the total neutrophils / total lymphocytes ratio and procalcitonin are early risk factors for mortality. The variables age, glucose, creatinine and total leukocytes stand out as the best predictors of mortality. A COVEB score &lt;1 indicates with a 100% probability that the patient with suspected COVID-19 will not die in the next 30 days.</AbstractText><CopyrightInformation>&#xa9;The Author 2020. Published by Sociedad Espa&#xf1;ola de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pascual G&#xf3;mez</LastName><ForeName>N F</ForeName><Initials>NF</Initials><AffiliationInfo><Affiliation>Natalia F. Pascual G&#xf3;mez, Servicio de An&#xe1;lisis cl&#xed;nicos. Hospital Universitario de la Princesa. C/Diego de Le&#xf3;n 62. CP: 28006. Madrid. 2&#xaa; Planta. Spain. nataliafernanda.pascual@salud.madrid.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monge Lobo</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Granero Cremades</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Figuerola Tejerina</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ramasco Rueda</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>von Wernitz Teleki</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Arrabal Campos</LastName><ForeName>F M</ForeName><Initials>FM</Initials></Author><Author ValidYN="Y"><LastName>Sanz de Benito</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><VernacularTitle>Potenciales biomarcadores predictores de mortalidad en pacientes COVID-19 en el Servicio de Urgencias.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Quimioter</MedlineTA><NlmUniqueID>9108821</NlmUniqueID><ISSNLinking>0214-3429</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007958" MajorTopicYN="N">Leukocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVO">Identificar qu&#xe9; biomarcadores realizados en la primera anal&#xed;tica de urgencias ayudan a estratificar seg&#xfa;n riesgo de mortalidad a pacientes COVID 19.</AbstractText><AbstractText Label="M&#xc9;TODO">Estudio observacional descriptivo y transversal realizado con datos recogidos de los pacientes con sospecha de COVID-19 en el Servicio de Urgencias del 24 de febrero al 16 de marzo del 2020. Se realiz&#xf3; el estudio univariante y multivariante para encontrar los marcadores independientes de mortalidad y calcular el riesgo mediante la construcci&#xf3;n de una escala de gravedad.</AbstractText><AbstractText Label="RESULTADOS">Se incluyeron 163 pacientes de los que fallecieron 33 y 29 de ellos resultaron positivos para la prueba PCR COVID-19. Obtuvimos como posibles factores para conformar el score de riesgo de mortalidad edad&gt;75 a&#xf1;os ((OR ajustada=12,347, IC95%: 4,138-36,845 p=0.001), leucocitos totales&gt; 11.000 cel/mm<sup>3</sup> (OR ajustada=2,649, IC95%: 0,879-7,981 p=0,083), glucosa&gt; 126 mg/dL (OR ajustada=3,716, IC95%: 1,247-11,074 p=0,018) y creatinina&gt;1,1 mg/dL (OR ajustada= 2,566, IC95%: 0,889-7,403, p=0,081). Este score se denomin&#xf3; COVEB (COVID, Edad, perfil B&#xe1;sico anal&#xed;tico) con un AUC 0,874 (IC95%: 0,816-0,933, p&lt;0.001; punto de corte= 1 (sensibilidad= 89,66% (IC95%: 72,6%-97,8%), especificidad= 75,59% (IC95%: 67,2%-82,8%). Un score &lt; 1 posee un valor predictivo negativo = 100% (IC95%: 93,51%-100%) y un valor predictivo positivo = 18,59% (IC95%: 12,82%-25,59%).</AbstractText><AbstractText Label="CONCLUSIONES">Las escalas cl&#xed;nicas de gravedad, los biomarcadores de funci&#xf3;n renal, los par&#xe1;metros del recuento leucocitario, el ratio neutr&#xf3;filos totales/linfocitos y procalcitonina son factores de riesgo tempranos de mortalidad. Destacan las variables edad, glucosa, creatinina y leucocitos totales como mejores predictores de mortalidad. Un score COVEB&lt; 1 indica con un 100% de probabilidad, que el paciente con sospecha de COVID-19 no va a fallecer en los pr&#xf3;ximos 30 d&#xed;as.</AbstractText><CopyrightInformation>&#xa9;The Author 2020. Published by Sociedad Espa&#xf1;ola de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">emergency</Keyword><Keyword MajorTopicYN="N">score</Keyword></KeywordList><CoiStatement>Los autores declaran no tener ning&#xfa;n conflicto de intereses.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32657550</ArticleId><ArticleId IdType="pmc">PMC7374038</ArticleId><ArticleId IdType="doi">10.37201/req/060.2020</ArticleId><ArticleId IdType="pii">pascual13jul2020</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>OMS. Organizaci&#xf3;n Mundial de la Salud. COVID-19: cronolog&#xed;a de la actuaci&#xf3;n de la OMS, 2020.  [cited 27 Apr 2020]. Available from: https://www.who.int/es/news-room/detail/27-04-2020-who-ti-meline---covid-19</Citation></Reference><Reference><Citation>Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. . Clinical charac-teristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708&#x2013;20. DOI: 10.1056/NEJMoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. . Antibody Res-ponses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019. Clin Infect Dis. 2020; DOI: 10.1093/cid/ciaa344</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa344</ArticleId><ArticleId IdType="pmc">PMC7184337</ArticleId><ArticleId IdType="pubmed">32221519</ArticleId></ArticleIdList></Reference><Reference><Citation>XIANG J, WEN J, YUAN X, Xiong S, ZHOU X, LIU C, et al. . Po-tential biochemical markers to identify severe cases among COVID-19 patients. medRxiv 2020031920034447; DOI: 10.1101/2020.03.19.20034447</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.19.20034447</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Zhang H, Mu S, Wei W, Jin C, Xue Y, et al. . Lactate dehy-drogenase, a Risk Factor of Severe COVID-19 Patients. medRxiv 2020032420040162 DOI: 10.1101/2020.03.24.20040162</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.24.20040162</ArticleId><ArticleId IdType="pmc">PMC7343511</ArticleId><ArticleId IdType="pubmed">32633729</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B, She J, Wang Y, Ma X. Utility of Ferritin, Procalcitonin, and C-reactive Protein in Severe Patients with 2019 Novel Coronavirus Disease. Res Sq. 2019;1&#x2013;13. DOI: 10.21203/rs.3.rs-18079/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-18079/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari D, Motta A, Strollo M, Banfi G, Locatelli M. Routine blood tests as a potential diagnostic tool for COVID-19 Clin Chem Lab Med. 2020. June 25;58(7):1095-1099. DOI: 10.1515/cclm-2020-0398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2020-0398</ArticleId><ArticleId IdType="pubmed">32301746</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J-W, Han T-W, Woodward M, Anderson CS, Zhou H, Chen Y-D, et al. . The impact of 2019 novel coronavirus on heart injury: A Sys-tematic review and Meta-analysis. Prog Cardiovasc Dis. 2020. April 16;S0033-0620(20)30080-3. doi: 10.1016/j.pcad.2020.04.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2020.04.008</ArticleId><ArticleId IdType="pmc">PMC7160645</ArticleId><ArticleId IdType="pubmed">32305557</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarzi-Puttini P, Giorgi V, Sirotti S, Marotto D, Ardizzone S, Rizzardi-ni G, et al. . COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheu-matol. 2020;38(2):337-342. PMid:</Citation><ArticleIdList><ArticleId IdType="pubmed">32202240</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermejo-Martin JF, Almansa R, Men&#xe9;ndez R, Mendez R, Kelvin DJ, Torres A. Lymphopenic community acquired pneumonia as signa-ture of severe COVID-19 infection. J Infect. 2020;80(5):e23-e24. doi: 10.1016/j.jinf.2020.02.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.02.029</ArticleId><ArticleId IdType="pmc">PMC7133663</ArticleId><ArticleId IdType="pubmed">32145214</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulia MS, O&#x2019;Brien TP, Hou PC, Schuman A, Sambursky R. Multi-tiered screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in response to pandemic. Ann Med. 2020;52(5):207-214. doi: 10.1080/07853890.2020.1763449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2020.1763449</ArticleId><ArticleId IdType="pmc">PMC7877955</ArticleId><ArticleId IdType="pubmed">32370561</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin S, Huang M, Li D, Tang N. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. J Thromb Thrombolysis. 2020;1-4. doi: 10.1007/s11239-020-02105-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02105-8</ArticleId><ArticleId IdType="pmc">PMC7124128</ArticleId><ArticleId IdType="pubmed">32246317</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubino S, Kelvin N, Bermejo-Martin JF, Kelvin D. As COVID-19 ca-ses, deaths and fatality rates surge in Italy, underlying causes re-quire investigation. J Infect Dev Ctries. 2020;14(3):265-267. doi: 10.3855/jidc.12734.</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.12734</ArticleId><ArticleId IdType="pubmed">32235086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministerio de sanidad E. Situaci&#xf3;n de COVID-19 en Espa&#xf1;a. Ministerio de Sanidad. Gobierno de Espa&#xf1;a, 2020.  [cited 23 May 2020]. Available from: https://cnecovid.isciii.es/covid19/</Citation></Reference><Reference><Citation>Liu J, Li S, Liu J, Liang B, Wang X, Wang H, et al. . Longitudinal cha-racteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine . 2020;55:102763. doi: 10.1016/j.ebiom.2020.102763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102763</ArticleId><ArticleId IdType="pmc">PMC7165294</ArticleId><ArticleId IdType="pubmed">32361250</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29077335</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2386-5857</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title><ISOAbbreviation>Emergencias</ISOAbbreviation></Journal><ArticleTitle>[Difficulties with the prescription and administration of antibiotics in routine hospital emergency department care: a survey study].</ArticleTitle><Pagination><StartPage>50</StartPage><EndPage>54</EndPage><MedlinePgn>50-54</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To detect the problems hospital emergency room staff have when prescribing and administering antibiotics.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">A 14-item questionnaire was designed to assess staff members' knowledge of the importance of starting antibiotic treatment promptly, assigning appropriate dosing intervals, adjusting for renal function, and switching to oral therapy. Agreement with each item was expressed on a 5-point Likert scale. Items with a rate of appropriate response of less than 75% were targeted for specific attention.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Two hundred questionnaires were distributed to the staff and 150 were returned completed (response rate, 75%). The following items were targeted for attention based on rates of appropriate response of less than 75%: clear medical orders (65%), understanding the implication of early empirical antibiotic therapy on prognosis in serious infections (67%), estimation of the prevalence of renal insufficiency (42%), assumption that a creatinine serum level under &lt; 1.6 mg/dL is safe (33%), use of glomerular filtration rate to adjust dose according to renal function (47%), and an understanding of switching from intravenous to oral treatment (60%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study revealed the difficulties medical and nursing staff have in prescribing and administering antibiotics in a hospital emergency department. The results can facilitate improvements in antibiotic therapy by pinpointing areas to target for specific training interventions or the design of electronic prescribing aids.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moncl&#xfa;s Cols</LastName><ForeName>Ester</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital Cl&#xed;nic, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicol&#xe1;s Ocejo</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital Cl&#xed;nic, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez S&#xe1;nchez</LastName><ForeName>Miquel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>&#xc1;rea de Urgencias, Hospital Cl&#xed;nic, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortega Romero</LastName><ForeName>Mar</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>&#xc1;rea de Urgencias, Hospital Cl&#xed;nic, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Detecci&#xf3;n mediante encuesta de las dificultades con las que se encuentra el personal sanitario en la prescripci&#xf3;n y administraci&#xf3;n de antibi&#xf3;ticos en la pr&#xe1;ctica cl&#xed;nica diaria de un servicio de urgencias hospitalario.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Emergencias</MedlineTA><NlmUniqueID>9805751</NlmUniqueID><ISSNLinking>1137-6821</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">Detectar las barreras con las que se encuentra el personal sanitario en la prescripci&#xf3;n y administraci&#xf3;n de antibi&#xf3;ticos en un servicio de urgencias hospitalario (SUH).</AbstractText><AbstractText Label="METODO" NlmCategory="METHODS">Se dise&#xf1;&#xf3; una encuesta con 14 &#xed;tems para valorar el grado de conocimiento de la importancia de la precocidad en el inicio de tratamiento antibi&#xf3;tico, los intervalos de dosificaci&#xf3;n adecuados, el ajuste a la funci&#xf3;n renal y la terapia secuencial. Las respuestas a cada &#xed;tem fueron cualitativas con 5 categor&#xed;as. Se consider&#xf3; que los &#xed;tems que obtuvieron una respuesta correcta menor del 75% precisaban de una intervenci&#xf3;n espec&#xed;fica.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">Se recogieron 150 encuestas cumplimentadas de las 200 repartidas entre el personal sanitario (tasa de respuesta del 75%). Los &#xed;tems con una respuesta correcta menor del 75% y que por tanto se consider&#xf3; que requer&#xed;an de una intervenci&#xf3;n espec&#xed;fica fueron: la claridad en la &#xf3;rdenes m&#xe9;dicas (65%), el conocimiento de la implicaci&#xf3;n del tratamiento antibi&#xf3;tico emp&#xed;rico precoz en el pron&#xf3;stico de las infecciones graves (67%), la estimaci&#xf3;n de la prevalencia de la insuficiencia renal (42%), un valor de creatinina s&#xe9;rica inferior a 1,6 mg/dl considerado como seguro (33%), el filtrado glomerular como par&#xe1;metro que se debe utilizar para ajustar la dosis a la funci&#xf3;n renal (47%) y el conocimiento de la terapia secuencial (60%).</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="CONCLUSIONS">Este estudio permite conocer las dificultades con las que se encuentra el personal sanitario a la hora de prescribir y administrar antibi&#xf3;ticos en un SUH y facilita el dise&#xf1;o de estrategias de mejora que incluyan desde formaci&#xf3;n espec&#xed;fica a t&#xe9;cnicas de prescripci&#xf3;n electr&#xf3;nica.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Administraci&#xf3;n de antibi&#xf3;ticos</Keyword><Keyword MajorTopicYN="N">Antibiotics, administration</Keyword><Keyword MajorTopicYN="N">Antibiotics, prescription</Keyword><Keyword MajorTopicYN="N">Encuestas</Keyword><Keyword MajorTopicYN="N">Estrategias de mejora.</Keyword><Keyword MajorTopicYN="N">Patient safety</Keyword><Keyword MajorTopicYN="N">Prescripci&#xf3;n de antibi&#xf3;ticos</Keyword><Keyword MajorTopicYN="N">Quality improvement</Keyword><Keyword MajorTopicYN="N">Seguridad del paciente</Keyword><Keyword MajorTopicYN="N">Surveys</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29077335</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24468300</PMID><DateCompleted><Year>2015</Year><Month>08</Month><Day>19</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-8865</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>Semergen</Title><ISOAbbreviation>Semergen</ISOAbbreviation></Journal><ArticleTitle>[A solitary kidney patient with diarrhea of 2 weeks duration].</ArticleTitle><Pagination><StartPage>e1</StartPage><EndPage>e4</EndPage><MedlinePgn>e1-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.semerg.2012.11.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1138-3593(12)00297-3</ELocationID><Abstract><AbstractText>The case is presented of a 78 year old woman with a history of congenital right renal, who suffered from diarrhea of approximately 2 weeks duration and discomfort due to cramp in both legs. The laboratory results showed severe hyperkalemia, hyponatremia, and slightly elevated creatinine levels, with no symptoms associated with this finding and with the rest of the normal laboratory results. She was admitted to the intensive care unit for treatment, and when her results returned to normal she was transferred to internal medicine. Among the other tests performed, the ACTH was shown to be high, and a left adrenal adenoma was found in the MR scan. The final diagnosis was Addison's syndrome. She was treated with mineralocorticoids with follow-up by internal medicine as an outpatient.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 Sociedad Espa&#xf1;ola de M&#xe9;dicos de Atenci&#xf3;n Primaria (SEMERGEN). Publicado por Elsevier Espa&#xf1;a. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>D&#xed;az Aguilar</LastName><ForeName>C M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias y Emergencias, Hospital de Montilla, C&#xf3;rdoba, Espa&#xf1;a. Electronic address: cdiazaguilar@yahoo.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Recio Ramirez</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias y Emergencias, Hospital de Montilla, C&#xf3;rdoba, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vega Romero</LastName><ForeName>M M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias y Emergencias, Hospital de Montilla, C&#xf3;rdoba, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calero Rojas</LastName><ForeName>M T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias y Emergencias, Hospital de Montilla, C&#xf3;rdoba, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Paciente monorrena con diarrea de 2 semanas de evoluci&#xf3;n.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2013</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Semergen</MedlineTA><NlmUniqueID>9610769</NlmUniqueID><ISSNLinking>1138-3593</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008901">Mineralocorticoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000224" MajorTopicYN="N">Addison Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003967" MajorTopicYN="N">Diarrhea</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006947" MajorTopicYN="N">Hyperkalemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007010" MajorTopicYN="N">Hyponatremia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008901" MajorTopicYN="N">Mineralocorticoids</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Addison's syndrome</Keyword><Keyword MajorTopicYN="N">Diarrea</Keyword><Keyword MajorTopicYN="N">Diarrhea</Keyword><Keyword MajorTopicYN="N">Hiperpotasemia</Keyword><Keyword MajorTopicYN="N">Hyperkalemia</Keyword><Keyword MajorTopicYN="N">S&#xed;ndrome de Addison</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2012</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24468300</ArticleId><ArticleId IdType="doi">10.1016/j.semerg.2012.11.003</ArticleId><ArticleId IdType="pii">S1138-3593(12)00297-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>